Petition For The Cure of Hepatitis C Colaboration Resolution

Drug companies always say patients come before profits, but that feels like nothing more than an empty slogan today.

BARCELONA (TheStreet) — The most effective new therapy for hepatitis C — two pills that could cure nearly every patient treated — may never see the light of day because the developers of these new medicines, Bristol-Myers Squibb(BMY) and Gilead Sciences(GILD), seem unable to work together.

Apparently, profits are more important than best patient care.

The new Hep C therapy at issue here combines Bristol’s daclatasvir with Gilead’s GS-7977. Each is a single pill administered once a day. The results from this new therapy are nothing short of spectacular — an early cure rate of 100% for genotype 1 patients and 91% of genotype 2/3 patients, according to data from a mid-stage study announced Thursday at the European Association for the Study of Liver Disease (EASL) meeting.

A 100% cure rate for genotype 1 patients! Obviously, results can’t get better than that.

You’d think there’d be a rush to move the combination regimen of daclatasvir and GS-7977 into a larger, confirmatory phase III trial, but you’d be mistaken. Amazingly, this most promising new treatment for hepatitis C patients may actually be discontinued because Bristol and Gilead can’t work together.

Good luck understanding why Bristol and Gilead can’t come together to help Hep C patients. The companies can’t even agree on the fact that the two companies are not agreeing.

“Given the strong SVR4 [early cure] data from the combo trial of daclatasvir (DCV) + GS-7977, and in the interest of advancing the science and for the benefit of patients, we were interested in a Phase III collaboration. Unfortunately Gilead was not interested,” said Bristol spokeswoman Cristi Barnett. Full Story Here.

 

Quoting from EATG:  “The most effective new therapy for hepatitis C — two pills that could cure nearly every patient treated — may never see the light of day because the developers of these new medicines, Bristol-Myers Squibb and Gilead Sciences, seem unable to work together. Apparently, profits are more important than best patient care. Best therapy combines Bristol’s daclatasvir with Gilead’s GS-7977.

 

Each is a single pill administered once a day. The results from this new therapy are nothing short of spectacular —an early cure rate of 100% for genotype 1 patients and 91% of genotype 2/3 patients, according to data from a mid-stage study announced Thursday at the European Association for the Study of Liver Disease (EASL) meeting. Amazingly, this most promising new treatment for hepatitis C patients may actually be discontinued because Bristol and Gilead can’t work together. Gilead needs to justify that $11 billion and deliver pro

These results were accomplished without interferon, a weekly injected drug that causes flu-like symptoms and other side effects that often lead patients to discontinue or delay treatment, or ribavirin, an older antiviral drug that is also currently part of all treatment regimens.

Over 170 million people worldwide have hepatitis C

Hepatitis C now kills more people than AIDS

Hepatitis C is a leading cause of liver cancer and liver transplant

Gilead Sciences – Put best patient care FIRST and the profits will FOLLOW!

” Please sign this petition to urge Gilead to work with Bristol-Myers Squibb on this drug combination for the benefit of those suffering with hepatitis C .

 

PLEASE SHARE AND ASK PEOPLE TO SIGN THIS ON YOUR FACEBOOK PAGE, TWITTER, EMAIL, HEALTH FORUMS, ETC.  ASK FAMILY, FRIENDS, CO-WORKERS, NEIGHBORS, ANYONE & EVERYONE!

NOTE TO SIGNERS:  IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT ME THROUGH CHANGE.ORG OR  MDUDLEY@SBCGLOBAL.NET

fits and returns to its shareholders. Collaborating with Bristol would more than likely dilute Gilead’s Hep C profits, which helps explain why Gilead isn’t exactly thrilled to push ahead. Hep C patients in need of convenient and potent new cures are being hurt.


PLEASE SUBSCRIBE FOR THE LATEST UPDATED INFORMATION. PLEASE LEAVE YOUR COMMENTS BELOW ON THIS SUBJECT. WHAT ARE YOUR THOUGHTS?

4 Responses to Petition For The Cure of Hepatitis C Colaboration Resolution

  1. This drug combination was tested in Phase II trials and it cured 100% of genotype 1, 2, 3 and even more importantly this cure was achieved without ribavirin. Ribavirin has possible side effects three-pages long, the most significant of these is life-threatening anemia.

    If Gilead had proceeded immediately into Phase III trials earlier this year (which you would expect a pharmaceutical company WOULD do since this is the most significant development in the history of HCV), these drugs would most likely have received Fast-Track status by the FDA and by now multiple thousands of people would have been cured and this drug combination would be on the market a lot sooner than any others currently in trial stages.

    If this were the “cure for cancer” would this be allowed to happen? We think NOT! This IS the “cure for hepatitis C” (without ribavirin or interferon)… a disease which afflicts more than 4 million Americans and over 170 million people worldwide. Hepatitis C now kills more people than AIDS and is the number one reason for liver transplants. The government needs to be involved and force Gilead Sciences to make this cure available now.

    Perhaps this is an unprecedented case for the government to exercise the “right of eminent domain”? Something must be done now. This is still the United States of America and we cannot allow people to continue suffering and dying when a big pharma company holds the key to this cure as it goes against everything our country stands for and there are just too many people infected and affected by this horrible disease. Gilead Sciences Board of Directors and their shareholders should consider that their “demographics” are literally dying off at the rate of 1000 people each day.

    When (not if), a vaccine is developed for HCV then there will be no “renewable resources” to treat…thankfully! And Gilead’s returns on their $11 billion dollar investment (at the expense of hundreds of thousands of human lives) will be greatly diminished!

  2. Robert Metoyer

    I have been on HepC treatment on two different occasions. If you are a hepc patient you know its no fun taking chemo treatment like the pegasus plan to treat your hep c. The second time I was told I would probably be cured with a different drug besides the riboviron in addition to the chem shots. I relapsed on that occasion also. If there is a 100% cure for Hep C. I sure wish someone in power would make the drug companies release their discovery to the public.

  3. This is definately a treatment needed; everyone whom I know said they really had a hard time with the conventional treatments for Hep-C. Time for something “tolerable” for the growing numbers of infected patients.

  4. need more information so ican possibly help others live a good life.

Leave a Reply

Your email address will not be published. Required fields are marked *